OnKure Therapeutics reprices 1.7 million underwater stock options to $4.14 per share
Reuters2026/08/13 10:04- Onkure Therapeutics set an option repricing effective Aug. 7, 2026 for underwater employee and consultant stock options.
- Eligible options were granted before Jan. 1, 2025 with exercise prices at or above $10 under the 2024 or 2021 plans.
- Repriced exercise price resets to $4.14 per share, matching the Class A closing price on the effective date.
- Early exercise triggers a premium price equal to the original strike unless service continues for 18 months for senior management.
- About 1.7 million shares of options were repriced; original strikes ranged from $13.99 to $24.59 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Double valuation gap + AI boom! Asian companies raise $28 billion in ADRs this year, hitting a six-year high; Citi says major deals are still to come
Citi points out that as Asian tech companies seek higher valuations and target the deep capital pools of the world's largest stock markets, more Asian firms are expected to choose to go public in the US.

NexLiving Communities declares dividend of $0.01 per share for quarter ending Sept. 30, 2026
SRH Total Return Fund declares quarterly distribution of $0.20 a share for October 2026
Hepion net loss widens to $1.25 million in Q2 2026; revenue flat at no revenue